Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging (Q77974747)
Jump to navigation
Jump to search
scientific article published on 01 July 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging |
scientific article published on 01 July 1999 |
Statements
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging (English)
Jerusalem G
Beguin Y
Fassotte MF
Najjar F
Paulus P
Rigo P